Effect of a weight-loss stabilization following a weight reduction with or without meal replacement on cardiometabolic risk in overweight women. A randomized controlled trial

Int J Food Sci Nutr. 2019 Jun;70(4):453-466. doi: 10.1080/09637486.2018.1537363. Epub 2019 Jan 9.

Abstract

The objective of this study was to examine the effect of a 3-month weight-loss-stabilization phase (phase 2) following a successful 3-month weight-loss phase (phase 1), including a conventional energy-restricted diet with (MR) or without (C) meal replacement, on the cardiometabolic risk profile in 80 overweight women. In phase 2, both groups continued to significantly reduce weight and sustained the significant decreases in waist circumference and LDL-C. During the study, folic acid concentration significantly increased in the MR-group, while homocysteine concentration significantly worsened in the C-group. After 6 months, the number of women with hypertriglyceridemic waist was significantly reduced in both the groups, however with metabolic syndrome and metabolically unhealthy abdominal obesity (MUHAO) only in the MR-group. In conclusion, both strategies were equally effective for weight loss and weight-loss stabilization. The micronutrient supplementation with MR seemed to have an additional beneficial impact on the cardiometabolic risk in the MR-group versus the C-group.

Keywords: Weight-loss stabilization; abdominal obesity; cardiometabolic risk factors; weight management; weight reduction.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Anthropometry
  • Cardiovascular Diseases / epidemiology*
  • Diet, Reducing*
  • Female
  • Folic Acid / blood
  • Homocysteine / blood
  • Humans
  • Meals
  • Metabolic Syndrome / epidemiology*
  • Middle Aged
  • Overweight / diet therapy*
  • Waist Circumference
  • Weight Loss*

Substances

  • Homocysteine
  • Folic Acid